New insights into the pharmacokinetics of vancomycin after oral and intravenous administration: an investigation in beagle dogs
Intestinal absorption of orally administered peptides is often negligible because one or more key requirements for successful absorption (water solubility, peptic resistance, mucosal permeation) are not met. Due to its high water solubility and stability in the gastro-intestinal tract, vancomycin is...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 March 2020
|
| In: |
Journal of pharmaceutical sciences
Year: 2020, Volume: 109, Issue: 6, Pages: 2090-2094 |
| ISSN: | 1520-6017 |
| DOI: | 10.1016/j.xphs.2020.03.012 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.xphs.2020.03.012 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0022354920301386 |
| Author Notes: | Max Sauter, Philipp Uhl, Andreas D. Meid, Gerd Mikus, Jürgen Burhenne, Walter E. Haefeli |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1751845400 | ||
| 003 | DE-627 | ||
| 005 | 20220819141001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210319s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xphs.2020.03.012 |2 doi | |
| 035 | |a (DE-627)1751845400 | ||
| 035 | |a (DE-599)KXP1751845400 | ||
| 035 | |a (OCoLC)1341398928 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sauter, Max |e VerfasserIn |0 (DE-588)1103516507 |0 (DE-627)86126813X |0 (DE-576)470642033 |4 aut | |
| 245 | 1 | 0 | |a New insights into the pharmacokinetics of vancomycin after oral and intravenous administration |b an investigation in beagle dogs |c Max Sauter, Philipp Uhl, Andreas D. Meid, Gerd Mikus, Jürgen Burhenne, Walter E. Haefeli |
| 264 | 1 | |c 20 March 2020 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.03.2021 | ||
| 520 | |a Intestinal absorption of orally administered peptides is often negligible because one or more key requirements for successful absorption (water solubility, peptic resistance, mucosal permeation) are not met. Due to its high water solubility and stability in the gastro-intestinal tract, vancomycin is an ideal model peptide for evaluating the factors influencing the critical step of mucosal permeation. Therefore, to support formulation development for the systemic oral delivery of peptide therapeutics, we investigated the pharmacokinetics of vancomycin in beagle dogs after intravenous and oral administration comparing enteric encapsulated drug to the drug in solution, which revealed mean absolute bioavailabilities of 0.27% and 1.66%, respectively. Additionally, in depth pharmacokinetic analyses of intravenously administered vancomycin revealed a deep compartment slowly releasing the compound over many hours into the blood. | ||
| 650 | 4 | |a bioavailability | |
| 650 | 4 | |a dogs | |
| 650 | 4 | |a peroral | |
| 650 | 4 | |a pharmacokinetics | |
| 650 | 4 | |a vancomycin | |
| 700 | 1 | |a Uhl, Philipp |e VerfasserIn |0 (DE-588)1112349391 |0 (DE-627)866420797 |0 (DE-576)476575230 |4 aut | |
| 700 | 1 | |a Meid, Andreas |d 1981- |e VerfasserIn |0 (DE-588)1076301991 |0 (DE-627)834660377 |0 (DE-576)445184582 |4 aut | |
| 700 | 1 | |a Mikus, Gerd |e VerfasserIn |0 (DE-588)110903137 |0 (DE-627)691097941 |0 (DE-576)336988710 |4 aut | |
| 700 | 1 | |a Burhenne, Jürgen |d 1963- |e VerfasserIn |0 (DE-588)1034228889 |0 (DE-627)745126987 |0 (DE-576)381858197 |4 aut | |
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pharmaceutical sciences |d Amsterdam : Elsevier, 1911 |g 109(2020), 6, Seite 2090-2094 |h Online-Ressource |w (DE-627)302718028 |w (DE-600)1491821-3 |w (DE-576)090855167 |x 1520-6017 |7 nnas |a New insights into the pharmacokinetics of vancomycin after oral and intravenous administration an investigation in beagle dogs |
| 773 | 1 | 8 | |g volume:109 |g year:2020 |g number:6 |g pages:2090-2094 |g extent:5 |a New insights into the pharmacokinetics of vancomycin after oral and intravenous administration an investigation in beagle dogs |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.xphs.2020.03.012 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0022354920301386 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210319 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 6 |y j | ||
| 998 | |g 1034228889 |a Burhenne, Jürgen |m 1034228889:Burhenne, Jürgen |d 910000 |d 910100 |e 910000PB1034228889 |e 910100PB1034228889 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 110903137 |a Mikus, Gerd |m 110903137:Mikus, Gerd |d 910000 |d 910100 |d 50000 |e 910000PM110903137 |e 910100PM110903137 |e 50000PM110903137 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 1076301991 |a Meid, Andreas |m 1076301991:Meid, Andreas |d 910000 |d 910100 |e 910000PM1076301991 |e 910100PM1076301991 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1112349391 |a Uhl, Philipp |m 1112349391:Uhl, Philipp |d 910000 |d 911400 |e 910000PU1112349391 |e 911400PU1112349391 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 1103516507 |a Sauter, Max |m 1103516507:Sauter, Max |d 910000 |d 910100 |e 910000PS1103516507 |e 910100PS1103516507 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1751845400 |e 3891058748 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title_sort":"Journal of pharmaceutical sciences","title":"Journal of pharmaceutical sciences"}],"titleAlt":[{"title":"Journal of the American Pharmaceutical Association"}],"note":["Gesehen am 07.02.13"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"302718028","part":{"extent":"5","volume":"109","year":"2020","text":"109(2020), 6, Seite 2090-2094","pages":"2090-2094","issue":"6"},"id":{"eki":["302718028"],"doi":["10.1002/(ISSN)1520-6017"],"zdb":["1491821-3"],"issn":["1520-6017"]},"name":{"displayForm":["American Chemical Society"]},"origin":[{"publisherPlace":"Amsterdam ; Washington, DC [u.a.] ; New York, NY","dateIssuedDisp":"1911-","dateIssuedKey":"1911","publisher":"Elsevier ; American Chemical Society and American Pharmaceutical Association ; Wiley"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"New insights into the pharmacokinetics of vancomycin after oral and intravenous administration an investigation in beagle dogsJournal of pharmaceutical sciences","pubHistory":["1.1911 -"]}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 19.03.2021"],"title":[{"title_sort":"New insights into the pharmacokinetics of vancomycin after oral and intravenous administration","title":"New insights into the pharmacokinetics of vancomycin after oral and intravenous administration","subtitle":"an investigation in beagle dogs"}],"physDesc":[{"extent":"5 S."}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"20 March 2020"}],"name":{"displayForm":["Max Sauter, Philipp Uhl, Andreas D. Meid, Gerd Mikus, Jürgen Burhenne, Walter E. Haefeli"]},"person":[{"display":"Sauter, Max","given":"Max","role":"aut","family":"Sauter"},{"family":"Uhl","role":"aut","given":"Philipp","display":"Uhl, Philipp"},{"role":"aut","family":"Meid","display":"Meid, Andreas","given":"Andreas"},{"given":"Gerd","display":"Mikus, Gerd","family":"Mikus","role":"aut"},{"display":"Burhenne, Jürgen","given":"Jürgen","role":"aut","family":"Burhenne"},{"given":"Walter E.","display":"Haefeli, Walter E.","family":"Haefeli","role":"aut"}],"id":{"doi":["10.1016/j.xphs.2020.03.012"],"eki":["1751845400"]},"recId":"1751845400"} | ||
| SRT | |a SAUTERMAXUNEWINSIGHT2020 | ||